V030-3012 Screening compound: N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-2-(4-chlorophenoxy)-N-cyclohexylacetamide

V030-3012 Screening compound: N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-2-(4-chlorophenoxy)-N-cyclohexylacetamide
V030-3012 Screening compound: N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-2-(4-chlorophenoxy)-N-cyclohexylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-3012
N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-2-(4-chlorophenoxy)-N-cyclohexylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-3012

Molecular Formula

C24H25BrClN3O3 (C24 H25 BrClN3 O3)

Compound Name

N-{2-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-2-(4-chlorophenoxy)-N-cyclohexylacetamide

IUPAC name

N-{2-[3-(4-bromophenyl)-124-oxadiazol-5-yl]ethyl}-2-(4-chlorophenoxy)-N-cyclohexylacetamide

SMILES

O=C(COc(cc1)ccc1Cl)N(CCc1nc(-c(cc2)ccc2Br)no1)C1CCCCC1

InChI

InChI=1S/C24H25BrClN3O3/c25-18-8-6-17(7-9-18)24-27-22(32-28-24)14-15-29(20-4-2-1-3-5-20)23(30)16-31-21-12-10-19(26)11-13-21/h6-13,20H,1-5,14-16H2

InChI Key

WAQXDEURVSIPPZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19781318

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

518.84

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.870

Distribution Coefficient, logD

6.870

Water Solubility, LogSw

-6.57

Polar Surface Area

53.716

Acid Dissociation Constant (pKa)

25.16

Base Dissociation Constant (pKb)

1.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

V030-3012 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with V030-3012 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-3012?
Check Price and Availability of V030-3012, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-3012 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-3012
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-3012
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-3012 available by request